Skip to main content

Search

COVID-19

COVID-19

COVID-19

INFECTIOUS DISEASES & VACCINES - COVID-19

As always, Janssen remains committed to healthcare professionals and patients, as well as to our employees and communities

WHAT IS JANSSEN DOING TO FIGHT THIS PANDEMIC?

 
 
 
 

Collaborate with regulators, healthcare organisations, institutions and communities worldwide

To help ensure our research platforms, existing science and outbreak expertise can be maximized to stem this public health threat.

WHAT IMPACT DOES COVID-19 HAVE ON US AS A COMPANY?

 
 
 

At Johnson & Johnson we’ve worked out a robust continuity plan to avoid disruption to our business

Learn more
 
 

We highly value our employees, their health, and the health of their families. Find out how we commit to keeping our colleagues safe

Learn more

The Latest Updates

Biopharma Leaders Unite To Stand With Science
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

Follow all latest updates via LinkedIn and Twitter

Back to Respiratory infections

Other focus areas

 
 
 
 

HIV